INTRODUCTION {#sec1-1}
============

Excised lesions of the conjunctiva include a wide spectrum of conditions ranging from benign lesions, such as pterygium, solid dermoid, nevus, papilloma, hemangioma and pyogenic granuloma, to precancerous ocular surface squamous neoplasia (OSSN) and aggressive malignancies, such as malignant melanoma, squamous cell carcinoma, or Kaposi's sarcoma.[@CIT1] The differentiation of these lesions is based on the patient's history, clinical, and histopathological features of the lesion. The conjunctiva is readily visible, so related lesions that occur in the conjunctiva are generally recognized at a relatively early stage.

There is a relative paucity of large published series documenting conjunctival lesions. A review of a large series of conjunctival biopsy specimens from an adults US population documented the following distribution: inflammatory/degenerative lesions (12%); benign epithelial (2%); pigmented (53%); premalignant and malignant epithelial (11%); lymphoid (8%); miscellaneous (12%); and congenital lesions (2%). [@CIT2] A similar series in the Indian population, reported 46% of the lesions were of epithelial origin (benign, premalignant, and malignant neoplasm). The remaining lesions included miscellaneous lesions (22%), degenerative lesions (14%), melanocytic tumors (12%), and lymphoid tumors (6%).[@CIT3] Squamous cell carcinoma occurred in 20% followed by chronic non-specific inflammation (12%), pterygium (10%), squamous papilloma (8%), and OSSN (8%).[@CIT3]

The aim of this retrospective study was to determine the frequency of the most commonly excised conjunctival lesions in a cohort of subjects with histopathologically confirmed diagnoses over a 10-year period.

MATERIALS AND METHODS {#sec1-2}
=====================

The data on conjunctival masses diagnosed in the pathology department were retrospectively analyzed from 1998 to 2008. Pterygia were excluded due to nonreferral of the majority of these lesions. Age, sex distribution of patients, and location of lesions were evaluated according to hospital pathological referral records. Hematoxylin and eosin stained sections from each biopsy specimen were examined. The final diagnosis in each case was established by a combination of history, ocular findings, and histopathology.

The Students t-test and analysis of variance (ANOVA) test were used to analyze continuous variables such as age whereas the Chi-square (χ2) test was used to analyze categorical variables such as sex and site of lesion. A *P*-value less than 0.05 was considered statistically significant.

RESULTS {#sec1-3}
=======

A total of 192 conjunctival specimens were examined in the pathology department in the decade spanning 1998 to 2008. Of this specimens, 106 (55.2%) were from males and 86 (44.8%) for females. The conjunctival specimens were referred to the pathology department due to suspicion of a conjunctival neoplasm because of rapid growth or for cosmetic reasons. The mean age of the cohort was 27.07 ± 17 years (range, 1.5--77 years), and the mode was 20 years (*P* = 0.0001, ANOVA). There was no significant difference in sex distribution (*P* = 0.149, Chi-square test). The distribution of the lesions is presented in [Table 1](#T0001){ref-type="table"}. Differences in mean age between the lesions are shown in [Table 2](#T0002){ref-type="table"}.

###### 

Distribution of excised conjunctival lesions in relation to the age and sex of the cohort

                             Number (%)   Age (years) (Mean + SD)                         Sex male (%):female (%)
  -------------------------- ------------ ----------------------------------------------- ----------------------------------------
  Pyogenic granuloma         59 (30.7)    30.99 ± 17.2                                    34 (57.6):25 (42.4)
  Nevus                      44 (22.9)    19.48 ± 10.57                                   21 (47.7):23 (52.3)
  Cyst                       23 (12)      28.26 ± 16.57                                   13 (56.5):10 (43.5)
  OSSN                       21 (10.9)    45.9 ± 16.7[\*](#T000F1){ref-type="table-fn"}   9 (40.9):12 (54.5)
  Hemangioma                 15 (7.8)     16.8 + 9.15                                     9 (60):6 (40)
  Papilloma                  10 (5.2)     25.9 ± 21.1                                     5 (50):5 (50)
  Dermolipoma                8 (4.2)      18.63 ± 8.16                                    4 (50):4 (50)
  Solid dermoid              3 (1.6)      5.0 ± 1.5                                       2:1
  BLH                        4 (2.1)      19.75 ± 7.59                                    3:1
  Nonspecific inflammation   4 (2.1)      28.25 ± 19.55                                   3:1
  Herniated orbital fat      1 (0.5)      30                                              0:1
  Total                      192          27.07 ± 17.02                                   106 (55.2):86
                                                                                          (44.8)
  *P* value                               0.0001[\*](#T000F1){ref-type="table-fn"}        0.149[†](#T000F2){ref-type="table-fn"}

OSSN - Ocular surface squamous neoplasia; BLH - benign lymphoid hyperplasia

Significant at *P* \< 0.05 (ANOVA),

Chi test

###### 

*P* values of the *t*-test of the differences in mean age between conjunctival lesions

  Disease                Pyogenic granuloma                         Nevus                                      Cystic                                    OSSN                                       Hemangioma                                 Papilloma                                 Dermolipoma                                Solid dermoid
  ---------------------- ------------------------------------------ ------------------------------------------ ----------------------------------------- ------------------------------------------ ------------------------------------------ ----------------------------------------- ------------------------------------------ ------------------------------------------
  Pyogenic granuloma     \-                                         0.0001[\*](#T000F3){ref-type="table-fn"}   0.516                                     0.001[\*](#T000F3){ref-type="table-fn"}    0.003[\*](#T000F3){ref-type="table-fn"}    0.41                                      0.05                                       0.0001[\*](#T000F3){ref-type="table-fn"}
  Nevus                  0.0001[\*](#T000F3){ref-type="table-fn"}   \-                                         0.01[\*](#T000F3){ref-type="table-fn"}    0.0001[\*](#T000F3){ref-type="table-fn"}   0.019[\*](#T000F3){ref-type="table-fn"}    0.19                                      0.169                                      0.023[\*](#T000F3){ref-type="table-fn"}
  Cystic                 0.516                                      0.013[\*](#T000F3){ref-type="table-fn"}    \-                                        0.001[\*](#T000F3){ref-type="table-fn"}    0.02[\*](#T000F3){ref-type="table-fn"}     0.732                                     0.128                                      0.025[\*](#T000F3){ref-type="table-fn"}
  OSSN                   0.001[\*](#T000F3){ref-type="table-fn"}    0.0001[\*](#T000F3){ref-type="table-fn"}   0.001[\*](#T000F3){ref-type="table-fn"}   \-                                         0.0001[\*](#T000F3){ref-type="table-fn"}   0.008[\*](#T000F3){ref-type="table-fn"}   0.0001[\*](#T000F3){ref-type="table-fn"}   0.0001[\*](#T000F3){ref-type="table-fn"}
  Hemangioma             0.003[\*](#T000F3){ref-type="table-fn"}    0.019[\*](#T000F3){ref-type="table-fn"}                                              0.0001[\*](#T000F3){ref-type="table-fn"}   \-                                         0.056                                     0.642                                      0.045
  Papilloma              0.41                                       0.19                                       0.732                                     0.008[\*](#T000F3){ref-type="table-fn"}    0.056                                      \-                                        0.373                                      0.125
  Dermolipoma            0.05                                       0.169                                      0.128                                     0.0001[\*](#T000F3){ref-type="table-fn"}   0.642                                      0.373                                     \-                                         0.021[\*](#T000F3){ref-type="table-fn"}
  Solid dermoid          0.0001[\*](#T000F3){ref-type="table-fn"}   0.023[\*](#T000F3){ref-type="table-fn"}    0.025[\*](#T000F3){ref-type="table-fn"}   0.0001[\*](#T000F3){ref-type="table-fn"}   0.045                                      0.125                                     0.021[\*](#T000F3){ref-type="table-fn"}    \-
  Lymphoid hyperplasia   0.20                                       0.96                                       0.329                                     0.006[\*](#T000F3){ref-type="table-fn"}    0.563                                      0.588                                     0.823                                      0.023[\*](#T000F3){ref-type="table-fn"}

OSSN - Ocular surface squamous neoplasia

Significant difference of the age between lesions with the *t*-test (*P* \< 0.05)

The most frequent lesions were pyogenic granulomas in 59 cases (30.7%) with correct clinical diagnoses in 55 cases. The four clinical misdiagnoses were carcinoma in situ, hemangioma, papilloma, and conjunctival cyst. Pyogenic granulomas diagnosed on the palpebral conjunctiva generally developed following chalazion excision (12 cases, 20.3%). Pyogenic granulomas of the bulbar conjunctiva were related to pterygium excision in 12 cases (20.3%), squint surgery in 1 case, and trauma in 3 cases (5.1%). No specific etiology was reported in 31 cases (52.5%). Pyogenic granulomas were clinically described as pedunculated or sessile soft vegetation of excessive granulation tissue. Histopathologically, these granulomas had dilated and congested capillaries separated by fibrotic stroma with variable grades of inflammatory cells infiltration \[[Figure 1](#F0001){ref-type="fig"}\]. Pyogenic granulomas significantly affected middle-aged patients with statistically significant differences from nevus, OSSN, hemangioma, and solid dermoid (*P* = 0.0001, 0.001, 0.003, and 0.0001, respectively; *t*-test) \[[Table 2](#T0002){ref-type="table"}\].

![A case of pedunculated pyogenic granuloma with a lobulated surface involving the palpebral conjunctiva after previous chalazion excision (A). Histopathologically, it had dilated and congested capillaries separated by fibrotic stroma with inflammatory cells infiltration (H and E, ×25) (B)](MEAJO-18-48-g001){#F0001}

Melanocytic nevi were the second most common benign conjunctival lesion (44 cases, 22.9%). These nevi occurred most commonly on the bulbar conjunctiva (65.9%, 29 cases), followed by the limbus (27.3%, 12 cases), the fornix, the caruncle, and outer canthus (one case each). Nevus excision was mostly due to rapid growth and/or cosmesis. Histopathologically, 38 cases (86.4%) were diagnosed as compound nevi with nests of nevus cells with junctional activity in the epidermodermal junction and the dermis. Of these, 18 cases showed excessive chronic inflammatory cells infiltration with numerous eosinophils, nine of them were accompanied with cystic spaces. Purely cystic compound nevi were detected in five cases \[Figures [2A](#F0002){ref-type="fig"}--[C](#F0002){ref-type="fig"}\]. Most of the inflamed and cystic nevi were juxtalimbal. Three subjects (6.8%), aged 10, 16, and 20 years, with lesion history since birth, were diagnosed with junctional nevi and nests of nevus cells in the epidermodermal junction \[[Figure 2D](#F0002){ref-type="fig"}\]. Primary acquired melanosis (PAM) without atypia occurred in two cases (4.5%). Subepithelial nevus was diagnosed in one case (2.3%).

![A case of compound nevus involving the bulbar conjunctiva (A). Nevus cells with junctional activity in the epidermodermal junction and the dermis with excessive chronic inflammatory cells infiltration (H and E, ×100) (B). Photomicrographs of; cystic nevus (C), junctional nevus with nevus cells at the epidermodermal junction (D) (C, D H and E, ×25)](MEAJO-18-48-g002){#F0002}

Conjunctival nevi occurred in younger patients with a mean age of 19.48 ± 10.57 years. There were significant differences from pyogenic granuloma, cystic lesions, OSSN, hemangioma, and solid dermoid (*P* = 0.0001, 0.01, 0.0001, 0.019, and 0.023, respectively, *t*-test).

There were 23 cystic lesions (12%), 16 (70%) of which were ductal retention cysts of which eight cases (34.8%) were occupying the fornix. Two cases of traumatic blood cysts and two cases of mucous glands retention cysts were located in the bulbar conjunctiva \[[Figure 3](#F0003){ref-type="fig"}\]. Epidermoid cysts were detected in three cases involving the caruncle. Cystic lesions in middle-aged patients occurred with significant difference from nevus, OSSN, hemangioma, and solid dermoid (*P* = 0.013, 0.001, 0.02, and 0.025, respectively, t-test). No significant difference from pyogenic granuloma was noted in middle-aged subjects (*P* = 0.516, t-test) \[[Table 2](#T0002){ref-type="table"}\].

![A retention cyst occupying the temporal fornix (A). Photomicrograph showed the cubical cell layer lining of the cyst with area of epithelium rich in goblet cells (H and E, ×25) (B)](MEAJO-18-48-g003){#F0003}

OSSN was detected in 21 cases (10.9%). The mean age of subjects affected with OSSN was 45.9 ± 16.7 (range from 22 to 77 years) with nine cases were older than 50 years. OSSN affected older patients compared to all other lesions ([Table 2](#T0002){ref-type="table"}, *P* \< 0.05, t-test). OSSN was clinically described as sessile, raised, and pink-to-reddish gray in color with irregular or gelatinous surface and well-defined edges. The limbal area was affected in 18 cases (85.7%) which was significantly different from other lesions (*P* = 0.0001, Chi-square test). Feeder vessels were reported in some cases. Histopathological examination revealed partial to full thickness replacement of conjunctival epithelium by dysplastic squamous cells, intact basement membrane, and an abrupt transition between the normal conjunctiva and the dysplastic area \[[Figure 4](#F0004){ref-type="fig"}\]. Although atypia was detected in 17 cases, invasive squamous cell carcinoma was not seen in any of the cases.

![Well-defined limbal OSSN encroaching over the cornea with gelatinous surface (A). Replacement of conjunctival epithelium by dysplastic squamous cells, thickening, and keratinization of superficial cells (atypia) (B). Sudden transition between normal and dysplastic area (arrow) with intact basement membrane (C). (B and C) H and E, ×25)](MEAJO-18-48-g004){#F0004}

Hemangiomas represented 7.8% (15 cases) with mean age of 16.8 ± 9.15 years. It affected younger patients with a significant difference from pyogenic granuloma, nevus, cystic lesions, and OSSN (*P* = 0.003, 0.019, 0.02, and 0.0001, respectively, t-test). Capillary hemangioma was detected in 9 of 15 hemangioma cases. Hemangioendothelioma was diagnosed in five cases and angiofibroma in one case. Hemangiomas occurred most commonly on the bulbar conjunctiva (10 cases).

Papilloma occurred in 10 cases (5.2%) involving the lacrimal punctum (three cases), caruncle (three cases), limbal (two cases), bulbar (one case), and palpebra (one case). It was clinically described as a pedunculated, papillary reddish lesion. Sessile papilloma was seen in limbal and palpebral cases. Histopathologically, it had a vascular connective tissue core lined by a hyperplastic epithelium. It significantly affected the younger and middle-aged patients with no significant difference from pyogenic granuloma, nevus, cystic lesions, and hemangiomas (*P* = 0.41, 0.19, 0.732, and 0.056, respectively, t-test) \[[Table 2](#T0002){ref-type="table"}\].

Eight cases (4.2%) of dermolipoma were described as yellowish subconjunctival mass involving the outer canthus with no palpable posterior margin. Dermolipomas were partially excised in most cases for cosmetic reasons due to posterior orbital extension. Histologically, there was excessive fat tissue with associated retention ductal cysts in some cases. Solid limbal dermoids were excised in three cases (1.6%) due to rapid growth that encroached the cornea and for cosmetic reasons. They were clinically described as solid elevated masses embedded in the superficial sclera and/or cornea on the inferior temporal globe or temporal limbus, with occasional fine protruding hairs. Histologic composition was fibrous tissue and occasional hair with sebaceous glands below the conjunctival epithelium.

Benign lymphocytic hyperplasia and chronic nonspecific inflammation occurred in four cases each, with a mean age of 19.75 ± 7.59 years and 28.25 ± 19.55 years, respectively. The benign lymphocytic hyperplasia was described as a salmon-pink conjunctival mass involving the caruncle or the fornix. Histologically, it had diffuse infiltration of the subepithelial tissue with mature lymphocytes and few lymphoid follicles. There was no accompanying systemic affection or regional lymphadenopathy as reported by a medical doctor. Patients' records included physical examination, complete blood cell count, erythrocyte sedimentation rate, and orbital computed tomography. Cases of chronic nonspecific inflammation showed multiple cell types such as lymphocytes, plasma cells, and occasional eosinophils.

With respect to site of occurrence for lesions, the bulbar conjunctiva was the most common site with 82 cases (42.7%), followed by the limbal area with 41 cases (21.4%), the palpebral conjunctiva with 30 cases (15.6%), and the caruncle with 16 cases (8.3%). There was a significant difference in localization between excised lesions (*P* = 0.0001, Chi-square test). The mean age for limbal, palpebral, and caruncular lesions was not significantly different (*P* = 0.063, ANOVA). There was a significant difference in mean age between limbal and bulbar lesions (*P* = 0.0001, ANOVA). [Table 3](#T0003){ref-type="table"} shows the distribution of excised lesions according to age and site.

###### 

Distribution of conjunctival lesions according to site and age

  Site            Number (%)                                 Age(mean ± SD)
  --------------- ------------------------------------------ -----------------------------------------
  Limbal          41 (21.4)                                  35.927 ± 20.34
  Bulbar          82 (42.7)                                  22.798 ± 14.12
  Palpebral       30 (15.6)                                  30.4 ± 14.86
  Caruncle        16 (8.3)                                   25.125 ± 19.24
  Fornix          11 (5.7)                                   22.727 ± 10.98
  Punctum         3 (1.6)                                    45.33 ± 28.59
  Outer canthus   9 (4.7)                                    17.11 ± 8.88
  Total           192                                        27.07 ± 17.021
  *P* value       0.0001[\*](#T000F4){ref-type="table-fn"}   0.0001[†](#T000F5){ref-type="table-fn"}

Significant (Chi-test),

Significant (ANOVA)

DISCUSSION {#sec1-4}
==========

This analysis of 192 conjunctival lesions can be used a representative sample of the Egyptian population. Studies on a large cohort of eyes can also be used for future comparative studies. In this study, the most common benign lesion that was excised was pyogenic granuloma. This contradicts a previous study on US subjects which reported an incidence of 1% for pyogenic granuloma \[[Table 4](#T0004){ref-type="table"}\].[@CIT2] Pyogenic granulomas were related to cases of chalazion, pterygium, and squint surgery in close to half the cases (47.5%). This outcome is consistent with earlier studies suggesting major trauma, subclinical infections, inflammation, or previous surgery as the major etiologic factor.[@CIT4][@CIT5] The lack of previous history in 52.5% of our cases would suggest that the lesions arose *de novo* from an unknown stimulus or insult. We did not find statistically significant differences in occurrence site or frequency between sexes which was different from Panda *et al*.[@CIT6] who suggested preponderance among males. The differences in sample size and characteristics may explain this difference between studies.

###### 

Lesion characteristics, frequency, and demographics of previous published studies in the United States[@CIT2], Iran[@CIT7], and India[@CIT3]

                                                    Shield *et al*.[@CIT2]   Amoli *et al*.[@CIT7]   Mondal *et al*.[@CIT3]                                                                                                
  ------------------------------------------------- ------------------------ ----------------------- ------------------------ --------------------------------- ----------- ------- --------- ------------- ------ ------- -------------------------------
  Choristoma                                        40 (2)                   26                      15 (38): 25 (62)         Bulbar                            25 (5.6)    11                \-                           
  Benign                                                                                                                                                                                                                   
   Epithelial (papillomas)                          38 (2)                   46                      30 (79): 8 (21%)         Limbal                            35 (7.8)    55.3              6 (12)                       
  Malignant                                                                                                                                                                                                                
   SCC                                              108 (6)                  66                      146 (81): 35 (19)        Limbal                            112(25.1)   58.63             10(20)        \>65   12:2    Bulbar and limbal
   CIN (OSSN)                                       71 (4)                                                                                                      25(5.6)     54.1              4(8)                         
   Actinic keratosis                                \-                                                                                                          17(3.8)     50.12             \-                           
   BCC                                              2 (\<1)                                                                                                     \-          \-                \-                           
   Mucoepidermoid carcinoma                         \-                                                                                                          1(0.2)      65                                             
  Melaocytic (total)                                872 (53)                 45                      394 (45): 478 (55)       Limbal                            173(38.7)   22.3              6 (12)                       Bulbar and limbal
  Nevus                                             454 (52)                                                                                                    10 (2.2)    40.5              Two cases                    
  PAM                                               180 (21)                                                                                                    18 (4)      59.39             One case                     
  MM                                                215 (25)                                                                                                    1 (0.2)     29                Three cases                  
  Secondary acquired melanosis                      \-                                                                                                                                                                     
  Vascular (total)                                  63 (4)                   39                      36 (57): 27 (43)         Bulbar                            23 (5.1)    22.26             2 (4)                        Palpebraland bulbar
  Pyogenic granuloma                                11 (1)                                                                                                                                                                 
  Hemangiomas                                       52 (3)                                                                                                                                                                 
  Cystic                                            27 (1)                                                                                                                                    3 (6)                        
  Fibrous                                           7 (\<1)                  39                      4 (57): 3 (43)           Bulbarand limbal                  2 (0.4)     59                                             
  Neural                                            1 (\<1%)                 49                      1 (100): 0 (0)           Limbal                            1 (0.2)     3                 \-                           
  Xanthoma                                          1 (\<1%)                 6                       1 (100): 0 (0%)          Limbal                            1 (0.2)     3                 \-                           
  Myxomatous                                        1 (\<1%)                 29                      0 (0): 1 (100)           Bulbar                            \-          \-                \-                           
  Lipomatous (total)                                23 (\<1%)                61                      13 (57): 10 (43)         Bulbar                            \-          \-                              \-             
  Herniated orbital fat                             20 (\<1)                                                                                                                                                               
  Lacrimal gland                                    12 (\<1%)                57                      6 (50): 6 (50)           Fornix                            \-          \-                \-                           
  Lymphoid (total)                                  128 (8%)                 57                      64 (50): 64 (50)         Fornix                            3 (0.7)     72                3 (6)                        Bulbar and fornix and diffuse
  Lymphoma                                                                                                                                                                                    Two cases                    
  BLH                                                                                                                                                                                         One case                     
  Leukemic                                          3 (\<1%)                 72                      1 (33): 2 (67)           Equal limbal, bulbar, palpebral   \-          \-                \-                           
  Metastatic                                        13 (\<1%)                54                      7 (54): 6 (46)           Bulbar                                                          \-                           
  Secondary                                         54 (3%)                  64                      22 (41): 32 (59)         Bulbar                                                          \-                           
  Degenerative and inflammatory simulating tumors   179 (12%)                48                      102 (50): 104 (50)       Bulbar                                                          16 (32)                      Bulbar
  Total                                             1643                                             842:801                                                    447         38.7    270:177   50                   34:16   

Age is expressed as mean M:F;male:female

Site represents the commonest site of affection

SCC - Squamous cell carcinoma; CIN - conjunctival intraepithelial neoplasia or OSSN; BCC - Basal cell carcinoma; MM - Malignant melanoma; BLH - benign lymphoid hyperplasia

In this study, nevi were the second commonly excised tumor, which contradicts the work of Amoli *et al*..[@CIT7] Similar to our study, the prevalence of compound nevi among young patients within the second decade of life with the majority involving the bulbar conjunctiva has been previously reported.[@CIT8][@CIT9] Rapid growth of compound nevi was attributed to cystic spaces and/or inflammatory cellular infiltration in 23 cases. Eosinophil infiltration suggested a high incidence of associated allergy.[@CIT10][@CIT11] The growth of the remaining nevi could be explained by nevus cells proliferation. Recently, high levels of mutated B-Raf proto-oncogene serine/threonine-protein kinase (BRAF) gene has been discovered in benign nevi. The mutated BRAF gene may activate the mitogen-activated protein kinase pathway, which stimulates multiple protein kinases that regulate cell proliferation, differentiation, and angiogenesis.[@CIT12]

Juxtalimbal PAM without atypia was present in two subjects aged 34 and 40 years with a history of increased pigmentation. The histologic examination did not reveal atypical melanocytes. Previous studies have reported that PAM with atypia carries a 13% risk of transformation to a malignant conjunctival melanoma.[@CIT13] Sun exposure was found to induce DNA damage of superficial epithelial cells with activation of transcription factors that stimulate increased expression of melanin-producing enzymes causing increased pigmentation.[@CIT14] Malignant melanoma was not detected in this study, which emphasizes the rarity of this lesion which has a reported incidence ranging from 0.2 to 0.8 per million in white- or fair-skinned populations.[@CIT15] Additionally benign nevi with mutated *BRAF* infrequently become malignant, suggesting additional genetic insults are necessary for malignancy.[@CIT12]

In this study, OSSN was the most frequent tumor in old age with nearly equal sex distribution despite previous report of a fivefold higher incidence among white males.[@CIT16] OSSN occurs in about 0.2--12 cases per 1,000,000 per year with geographic and ethnic variations.[@CIT17] In our study, there were 11 cases younger than 50 years although occurrence of OSSN below 50 years of age is rare with very few cases reported in the literature.[@CIT18] Causative factors that contribute to OSSN include ultraviolet light (UV-B) exposure, ocular trauma, predisposing genetic factors, and HPV human papilloma virus or human immune virus infection.[@CIT19] These premalignant neoplasms can develop into invasive squamous cell carcinoma characterized by increased thickness of epithelial dysplastic changes, invasion into the substantia propria with malignant squamous epithelial cell with keratin-filled epithelial pearl formation in well-differentiated tumors. The tumor then grows slowly, invading nearby tissues including the globe, eyelids, and orbital tissues leading to severe visual loss, loss of the eye, and severe facial deformities.[@CIT1]

In this study, four cases of benign reactive lymphoid hyperplasia were detected. Two subjects only 14 years of age and the oldest was 30 years. Three of the subjects were males in accordance with previous reports that suggested higher incidence among males.[@CIT20] We found very few cases of benign lymphoid hyperplasia affecting children documented in the literature.[@CIT21] Reactive lymphoid hyperplasia were considered a gray zone with difficult histopathologic differentiation from malignant lymphoma. Histologically, they consist of small lymphocytes with absent Dutcher bodies (intranuclear eosinophilic inclusions) and limited mitosis within the germinal centers of lymphoid follicles.[@CIT1] Immunophenotyping and immunogenotyping show polyclonal T- and B-cell infiltrates with positive anti-CD-20 (a B-cell marker) and anti-CD-45RO (a T-cell marker) immunoreactivity.[@CIT21] There was negative association with Epstein Barr virus.[@CIT21] The distinction between benign lymphoid hyperplasia and malignant lymphoma necessitated adequate immunohistochemistry and flow cytometry to detect the monoclonal antibodies characteristic of malignant lymphoma. The progression into malignant lymphoma, although rare in conjunctival cases,[@CIT21] has been reported within 1 year and 3.5 years in some case reports.[@CIT22]

First, one limitation of our study is the lack of follow-up of the cases in this cohort. Second, a systemic evaluation was not possible due to the retrospective nature of the study and retrieval of data from previous records.

In this study, bulbar lesions were excised mainly from young patients, most of which were nevi. Meanwhile, limbal lesions were excised from older patients, including 18 cases of OSSN and 12 cases of juxtalimbal nevi. The limbal epithelium, being rich in stem cells, was considered a common site for limbal tumors. UV-B or HPV could induce stem cell gene *p*53 (tumor suppressor gene) mutations and transformation into malignancy.[@CIT19][@CIT23] Hence a lesion that increases in size on the bulbar conjunctival should be considered for biopsy because of a have high incidence of malignant melanoma.[@CIT18] However, most lesions of the caruncle were benign with exception lymphoid hyperplasia that may progress to malignant lymphoma.

In conclusion, this study showed that the most common lesions in an Egyptian cohort were pyogenic granulomas and nevi (mostly compound nevus). Most benign conjunctival tumors were excised at a young age, meanwhile precancerous OSSN was excised in older subjects. The bulbar conjunctiva and limbal area were the most frequent sites of conjunctival tumors, therefore early diagnosis and excision were performed. The absence of truly cancerous lesions suggested their rarity and emphasized the role of early excision of any enlarging lesion in preventing malignant transformation. Results of this study provide a basic source of information on benign conjunctival tumors in an Egyptian population which may be useful for diagnosis and therapy of these tumors, while avoiding overly aggressive treatment for benign or precancerous lesions.
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